Lucien Hordijk, Priti Patnaik, freelance journalistsAmsterdam and Genevalucienhordijk{at}gmail.compatnaik.reporting{at}gmail.comCovid vaccine equity remains out of reach, as wealthy nations drag their feet on donations, and vaccine stocks pass their use-by dates, write Lucien Hordijk and Priti PatnaikOn 21 December 2021, a truck piled with brown cardboard boxes drove to the Goja rubbish dump in Abuja, Nigeria. Inside the boxes were a million doses of AstraZeneca’s covid-19 vaccine, which were tipped onto the heap, among dirty plastic bags and papers.Two months earlier, Nigeria had agreed to receive 2.6 million doses of the vaccine from the Covax facility, an initiative set up to distribute covid-19 vaccines equitably worldwide. The vaccines, in large part coming from Europe, had been close to expiry. “Some of these vaccines came in with a shelf life of about four weeks,” said Faisal Shaibu, a Nigerian government official tasked with organising vaccination of the country’s 200 million population against covid-19. Following quality inspections and regional allocations, Nigeria administered 1.53 million doses. But the rest were thrown away.